Applied Therapeutics Inc (APLT)
8.69
-0.32
(-3.55%)
USD |
NASDAQ |
Nov 15, 16:00
8.79
+0.10
(+1.15%)
After-Hours: 20:00
Applied Therapeutics Research and Development Expense (TTM): 52.35M for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 52.35M |
| June 30, 2024 | 48.31M |
| March 31, 2024 | 50.19M |
| December 31, 2023 | 53.91M |
| September 30, 2023 | 50.70M |
| June 30, 2023 | 53.03M |
| March 31, 2023 | 56.54M |
| December 31, 2022 | 55.63M |
| September 30, 2022 | 59.27M |
| June 30, 2022 | 63.75M |
| March 31, 2022 | 63.15M |
| December 31, 2021 | 62.57M |
| Date | Value |
|---|---|
| September 30, 2021 | 60.66M |
| June 30, 2021 | 63.01M |
| March 31, 2021 | 68.96M |
| December 31, 2020 | 61.79M |
| September 30, 2020 | 61.74M |
| June 30, 2020 | 49.25M |
| March 31, 2020 | 32.75M |
| December 31, 2019 | 32.35M |
| September 30, 2019 | 23.94M |
| June 30, 2019 | 19.21M |
| March 31, 2019 | 16.90M |
| December 31, 2018 | 11.47M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
32.35M
Minimum
Dec 2019
68.96M
Maximum
Mar 2021
54.99M
Average
56.09M
Median
Research and Development Expense (TTM) Benchmarks
| ResMed Inc | 311.34M |
| Axonics Inc | 47.05M |
| Organon & Co | 473.00M |
| NovaBay Pharmaceuticals Inc | 0.064M |
| Palatin Technologies Inc | 22.40M |